Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 16,558 shares at $45.16 ($748K) on 2024-12-31, disclosed to the SEC on 2025-01-03.
Scheduled sale ($748k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.16 | 8,279 | $374K | 50.0% |
| 2 | $45.16 | 8,279 | $374K | 50.0% |
| Total | $45.16 avg | 16,558 | $748K | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |